OR WAIT null SECS
Check out the latest features and columns!
Ukraine invasion tests the resiliency and quick action of CROs and sponsors
ACT's biennial Salary Survey takes a look at the future of industry following increased adaptation of decentralized technology
January 23, 2023
National site network continues expansion, partners with Moderna on CMVictory Trial.
Strategic acquisition enables Tigermed to enhance its services in Europe.
The latest business and people happenings of the last month, all in one place.
January 19, 2023
Latest recommendation places great emphasis on patients.
January 17, 2023
THREAD will serve as the sole provider of DCTs and eCOA technology under new five-year collaboration.
New patient-reported outcome measure developed in collaboration with The Epilepsy Study Consortium.
Renewed interest in psychedelic research shows great promise for patients in need of more effective therapies.
January 16, 2023
New public benefit corporation seeks to unlock access to traditionally siloed data through RWD platform.
New index will score pharma companies on clinical trial diversity and appear in BMJ Medicine.
January 13, 2023
Study in collaboration with the Medical Research Council Epidemiology Unit at the University of Cambridge showed participants had high levels of engagement in remote COVID-19 study.